Candel Therapeutics, Inc. (CADL) Earnings
|
Expand Research on CADL
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +16.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +4.0% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/26/26  |
Q425 | N/A | -$0.25 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/11/25 |
Q325 | N/A | -$0.18 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/10/25 |
Q325 | N/A | -$0.18 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/7/25 |
Q325 | N/A | -$0.18 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/6/25 |
Q325 | N/A | -$0.18 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/13/25 | Q325 | -$0.21 | -$0.18 | -$0.03 | N/A | N/A | N/A |  | | Details | |
| 8/14/25 |
Q225 | -$0.09 | -$0.16 | +$0.07 | N/A | N/A | N/A | | | Details | |
| 5/13/25 |
Q125 | $0.13 | -$0.37 | +$0.50 | N/A | N/A | N/A | | | Details |
